STOCK TITAN

Director files Form 144 to sell RVMD shares (NASDAQ: RVMD)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RVMD filed a Form 144 reporting a proposed sale of Common Stock. The notice lists restricted stock unit grants dated 03/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025 with line-item amounts shown in the excerpt. The filing is a routine sale notice; timing and proceeds treatment are not provided in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 sale notice listing RSU-originated shares.

The excerpt lists Common Stock tied to restricted stock unit grants on 03/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025

Timing, exact number being offered for sale, and cash‑flow recipient language are not shown in the provided text; subsequent filings or broker confirmations will clarify execution details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RVMD's Form 144 mean?

A Form 144 notifies the SEC of an intended sale of restricted or control securities. The excerpt lists RSU grant dates and line-item amounts; it does not state sale timing or proceeds recipient. Further filing details or broker notices will show execution specifics.

Which securities are referenced in the RVMD excerpt?

The excerpt references Common Stock derived from restricted stock unit grants dated 03/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025. Line items show numeric grant counts in the excerpt but not the sale quantity.

Does the Form 144 excerpt show how many RVMD shares will be sold?

The excerpt shows grant-related counts (e.g., 704, 596, 480, 502) but does not explicitly label an aggregate number as the amount to be sold. The filing excerpt does not provide a clear single "shares to be sold" figure or total proceeds.

Will RVMD receive proceeds from the sale in this Form 144?

The excerpt does not state whether the issuer will receive proceeds. Form 144s commonly reflect sales by holders; the cash‑flow treatment is not included in the provided text and requires the complete filing or related disclosure.

Where can I find execution or timing details for the RVMD sale?

Execution timing and sale method are not present in the excerpt. Look for follow-up broker reports, a completed Form 4 or additional SEC submissions that disclose sale dates, quantities sold, and any Rule 10b5-1 plan information.
Revolution Medicines, Inc.

NASDAQ:RVMD

View RVMD Stock Overview

RVMD Rankings

RVMD Latest News

RVMD Latest SEC Filings

RVMD Stock Data

18.84B
190.54M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
REDWOOD CITY